Computed Tomography trials for Stage III Pancreatic Cancer AJCC v8
All Computed Tomography trials · All Stage III Pancreatic Cancer AJCC v8 trials
10
Recruiting trials
Phase breakdown
Early Phase 1 1Phase 1 5Phase 2 4Phase 3 2
Recruiting trials studying Computed Tomography for Stage III Pancreatic Cancer AJCC v8
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
- Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Common questions
How many trials study Computed Tomography for Stage III Pancreatic Cancer AJCC v8?
10 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.